Fusion with pep-1, a cell-penetrating peptide, enhances the transmembrane ability of human epidermal growth factor. Issue 3 (3rd March 2016)

• Record Type: Journal Article
• Authors: Luo, Xue-Gang; Ma, De-Yun; Wang, Yue; Li, Wen; Wang, Chong-Xi; He, Ying-Ying; Gu, Xiang-Chao; Li, Xiu-Mei; Zhou, Hao; Zhang, Tong-Cun
• Is Part Of: Bioscience, biotechnology, and biochemistry. Volume 80:Issue 3(2016)
• Page Start: 584
• Page End: 590
• Publication Date: 2016-03-03
• Subjects: EGF -- expression -- Pep-1 -- E. coli -- transmembrane; Biotechnology -- Periodicals; Biochemistry -- Periodicals; 660.6
• DOI: 10.1080/09168451.2015.1091714
• Languages: English
• ISSNs: 0916-8451

Abstract

Abstract: Administration of macromolecule compositions in medicine and cosmetics always exhibited low bioavailability due to the limitation of transmembrane transport. Here, human epidermal growth factor (hEGF) was fused with glutathione S-transferase (GST) and Pep-1, the first commercial cell-penetrating peptide, in Escherichia coli . The fusion protein was firstly purified with the affinity chromatography, and then the GST tag was released by TEV protease. Final purification was achieved by the ion exchange chromatography. The biological activities and the transmembrane ability of the obtained products were determined using scratch wound-healing assay, MTT analysis, and immunofluorescence assay. The results showed that both rhEGF and Pep-1-fused hEGF were soluble expressed in E. coli . The fusion of Pep-1 could markedly increase the transmembrane ability of EGF, whereas it did not interfere with the growth-stimulating and migration-promoting functions of hEGF on fibroblasts. This research provided a novel strategy for the transmembrane transport of protein-derived cosmetics or drugs. Graphical abstract: : Fusion with pep-1, a cell-penetrating peptide, enhances the transmembrane ability of human EGF.